{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T20:30:29Z","timestamp":1649017829929},"reference-count":2,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Janssen Pharmaceuticals and EUSA Pharma for the ACCELERATE Natural History Registry and study drug"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1093\/clinchem\/hvaa156","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:12:36Z","timestamp":1594667556000},"page":"1378-1379","source":"Crossref","is-referenced-by-count":0,"title":["Commentary on A Case of Rapid Deterioration with Marked Hypergammaglobulinemia"],"prefix":"10.1093","volume":"66","author":[{"given":"David C","family":"Fajgenbaum","sequence":"first","affiliation":[{"name":"Center for Cytokine Storm Treatment & Laboratory (CSTL), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis D","family":"Phillips","sequence":"additional","affiliation":[{"name":"Center for Cytokine Storm Treatment & Laboratory (CSTL), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"2020120415571077100_hvaa156-B1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"2020120415571077100_hvaa156-B2","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","article-title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","volume":"132","author":"van Rhee","year":"2018","journal-title":"Blood"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/66\/11\/1378\/34709895\/hvaa156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/66\/11\/1378\/34709895\/hvaa156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T06:40:40Z","timestamp":1607150440000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/66\/11\/1378\/5953558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":2,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,10,28]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaa156","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,10,28]]}}}